Stock Ticker

Urinary tract infection drug recalled

by David J. Neal

tablets
Credit: Unsplash/CC0 Public Domain

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination.

The appearance of spots “was reported in a product quality complaint,” Amneal Pharmaceuticals said in its FDA-posted recall notice about Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg.

As for what problems this might cause, Amneal’s notice said, “Oral products contaminated with Aspergillus may result in serious and life-threatening infections. The use of the defective product in patients with underlying immunosuppressive conditions increases the concern for serious infections.”

Sulfamethoxazole/Trimethoprim is used for UTIs caused by a broad list of strains, among which are E. coli; middle-ear infections in children; aka pneumococcus, which the Cleveland Clinic says can cause pneumonia, sepsis or ; and “traveler’s diarrhea.”

Recalled tablets with 400 mg of Sulfamethoxazole and 80 mg Trimethoprim went to wholesalers and distributors around the nation from Dec. 4 through May 15. If you have these tablets but got them before Dec. 4, you’re safe.

2025 Miami Herald. Distributed by Tribune Content Agency, LLC.

Citation:
Urinary tract infection drug recalled (2025, June 6)
retrieved 6 June 2025
from https://medicalxpress.com/news/2025-06-urinary-tract-infection-drug-recalled.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Get RawNews Daily

Stay informed with our RawNews daily newsletter email

Liverpool defender left out of World Cup squad

Madonna Covering Rent For Musicians Working At Her Old NYC Rehearsal Space

Up 16.5%! Here’s why Hollywood Bowl stock smashed the FTSE 250 today

Trump says Iran would not get sanctions relief in exchange for giving up enriched uranium